Immune Monitoring during Therapy Reveals Activitory and Regulatory Immune Responses in High-Risk Neuroblastoma

SIMPLE SUMMARY: Neuroblastoma is a type of childhood cancer accounting for approximately 15% of childhood cancer deaths. Despite intensive treatment, including immunotherapy, prognosis of high-risk neuroblastoma is poor. Increasing amounts of research show that the fighting capacity of the immune sy...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Szanto, Celina L., Cornel, Annelisa M., Tamminga, Sara M., Delemarre, Eveline M., de Koning, Coco C. H., van den Beemt, Denise A. M. H., Dunnebach, Ester, Tas, Michelle L., Dierselhuis, Miranda P., Tytgat, Lieve G. A. M., van Noesel, Max M., Kraal, Kathelijne C. J. M., Boelens, Jaap-Jan, Huitema, Alwin D. R., Nierkens, Stefan
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8123570/
https://ncbi.nlm.nih.gov/pubmed/33926057
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13092096
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados